| Into His Rest Ministries | |
|
102 Elizabeth St Buchanan MI 49107-1327 | |
| (269) 471-6375 | |
| Not Available |
| Full Name | Into His Rest Ministries |
|---|---|
| Speciality | Social Worker |
| Location | 102 Elizabeth St, Buchanan, Michigan |
| Authorized Official Name and Position | David Sedlacek (OWNER) |
| Authorized Official Contact | 2694716375 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Into His Rest Ministries 102 Elizabeth St Buchanan MI 49107-1327 Ph: (269) 471-6375 | Into His Rest Ministries 102 Elizabeth St Buchanan MI 49107-1327 Ph: (269) 471-6375 |
| NPI Number | 1235526260 |
|---|---|
| Provider Enumeration Date | 04/16/2015 |
| Last Update Date | 04/16/2015 |
| Medicare PECOS PAC ID | 4587985890 |
|---|---|
| Medicare Enrollment ID | O20150611000706 |
News Archive
The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universitaet Muenchen), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer.
The cover for issue 29 of Oncotarget features, "In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model," by Lara, et al. which reported that adaptor proteins such as growth factor receptor-bound protein-2 play important roles in cancer cell signaling.
SeraCare Life Sciences, Inc. today announced that the Company has launched a set of new products in its diagnostic controls and panels portfolio—the SeraCare HIV-1 Seroconversion Panels. Each of the six panels consists of a set of undiluted plasma samples from a single plasma donor collected over a period of time during the development of detectable specific antibodies to HIV in the blood, or seroconversion, and is highly characterized with enhanced product information.
Scientists at the Helmholtz Zentrum München have for the first time decrypted the interaction network of hepatitis C virus proteins in living human cells. Their findings will contribute to a better understanding of the mechanisms behind inflammatory liver disease caused by hepatitis C viruses and open up new avenues for therapy development.
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235526260 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1041C0700X (Michigan) | Primary |
News Archive
The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universitaet Muenchen), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer.
The cover for issue 29 of Oncotarget features, "In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model," by Lara, et al. which reported that adaptor proteins such as growth factor receptor-bound protein-2 play important roles in cancer cell signaling.
SeraCare Life Sciences, Inc. today announced that the Company has launched a set of new products in its diagnostic controls and panels portfolio—the SeraCare HIV-1 Seroconversion Panels. Each of the six panels consists of a set of undiluted plasma samples from a single plasma donor collected over a period of time during the development of detectable specific antibodies to HIV in the blood, or seroconversion, and is highly characterized with enhanced product information.
Scientists at the Helmholtz Zentrum München have for the first time decrypted the interaction network of hepatitis C virus proteins in living human cells. Their findings will contribute to a better understanding of the mechanisms behind inflammatory liver disease caused by hepatitis C viruses and open up new avenues for therapy development.
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
› Verified 9 days ago
John M Berecz Phd Abpp Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2117 Grange Rd, Buchanan, MI 49107 Phone: 269-470-9999 | |
Snyder Therapy & Wellness Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 324 E Dewey St, Buchanan, MI 49107 Phone: 269-845-9401 | |
Fellows Counseling & Consulting Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 324 E Dewey St Ste 204, Buchanan, MI 49107 Phone: 269-697-1673 Fax: 269-666-6577 |